Sutter Martin P's Form 4 filing
Abiomed Inc (ABMD) · filed Nov 17, 2022
- Accession no.
- 0001415889-22-011489
- Filed
- Nov 17, 2022
- Trade date
- Nov 15-16, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market sales total $1.50M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sutter Martin PCIK 0001017832 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 15, 2022 | Common Stock, $0.01 par value | SSaleDisposed | −1,133 | $374.18 | −$423,945.94 | 122,237 | Direct | |
| Nov 15, 2022 | Common Stock, $0.01 par value | SSaleDisposed | −867 | $374.92 | −$325,055.64 | 121,370 | Direct | |
| Nov 16, 2022 | Common Stock, $0.01 par value | SSaleDisposed | −1,859 | $374.66 | −$696,492.94 | 119,511 | Direct | |
| Nov 16, 2022 | Common Stock, $0.01 par value | SSaleDisposed | −141 | $375.56 | −$52,953.96 | 119,370 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.